References:
1.Tanveer M, Tahir F, Majid Z, Mustafa Hussain M, Ali Asghar S, Qadar LT, Wasti J, Shahid A, Tasleem I, Khan HA, Sami M, Arsalan Q. Awareness and Self Care Practices of Elderly Men Regarding Prostate Diseases in Karachi, Pakistan. Cureus. 2019 May 8;11(5):e4617. doi: 10.7759/cureus.4617. PMID: 31312544; PMCID: PMC6615585.
2. Lim KB. Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol. 2017 Jul;4(3):148-151. doi: 10.1016/j.ajur.2017.06.004. Epub 2017 Jun 9. PMID: 29264223; PMCID: PMC5717991.
3. Singam, P., Hong, G. E., Ho, C., Hee, T. G., Jasman, H., Inn, F. X., ... & Zainuddin, Z. (2015). Nocturia in patients with benign prostatic hyperplasia: evaluating the significance of ageing, co-morbid illnesses, lifestyle and medical therapy in treatment outcome in real life practice. The Aging Male, 18(2), 112-117.
4. Malaysian Urological Association. 2023. Benign Prostate Enlargement. Retrieved from https://mua.my/urological-conditions/benign-prostate-enlargement-bph/
5. Nassar, G. N., & Leslie, S. W. (2022). Physiology, testosterone [Updated 2022 Jan 4]. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
6. Kinter, K. J., & Anekar, A. A. (2022). Biochemistry, dihydrotestosterone. In StatPearls [Internet]. StatPearls Publishing.
7. Kwon Y. Use of saw palmetto (Serenoa repens) extract for benign prostatic hyperplasia. Food Science and Biotechnology. 2019 Dec;28(6):1599-1606. DOI: 10.1007/s10068-019-00605-9. PMID: 31807332; PMCID: PMC6859144.
8. Sinescu, I., Geavlete, P., Multescu, R., Gangu, C., Miclea, F., Coman, I., ... & Feciche, B. (2011). Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia. Urologia internationalis, 86(3), 284-289.
This information is provided by Groway for education purposes only. It should not be used to substitute medical diagnosis.